Screener
Revvity RVTY Asia — Segment revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Revvity’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000031791-26-000019
| Line item | Reportable Segments / Three Months Ended / April 5, 2026 / Life Sciences | Reportable Segments / Three Months Ended / April 5, 2026 / Diagnostics | Reportable Segments / Three Months Ended / April 5, 2026 / Total | Reportable Segments / Three Months Ended / March 30, 2025 / Life Sciences | Reportable Segments / Three Months Ended / March 30, 2025 / Diagnostics | Reportable Segments / Three Months Ended / March 30, 2025 / Total |
|---|---|---|---|---|---|---|
| Primary geographical markets | ||||||
| Americas | $185,551 | $130,441 | $315,992 | $184,279 | $120,350 | $304,629 |
| Europe | 91,695 | 131,351 | 223,046 | 76,022 | 105,770 | 181,792 |
| Asia | 84,599 | 87,481 | 172,080 | 80,094 | 98,247 | 178,341 |
| $361,845 | $349,273 | $711,118 | $340,395 | $324,367 | $664,762 | |
| Major goods/service lines | ||||||
| Life Sciences Solutions | $299,996 | — | $299,996 | $286,453 | — | $286,453 |
| Software | 61,849 | — | 61,849 | 53,942 | — | 53,942 |
Item 1.Unaudited Financial Statements
FAQ
- What is Revvity's asia — segment revenue?
- Revvity (RVTY) reported asia — segment revenue of $172.08M in Q1 2026.
- How has Revvity's asia — segment revenue changed year-over-year?
- Revvity's asia — segment revenue decreased by 3.5% year-over-year, from $178.34M to $172.08M.
- What is the long-term trend for Revvity's asia — segment revenue?
- Over 4 years (2021 to 2025), Revvity's asia — segment revenue has grown at a -6.5% compound annual growth rate (CAGR), from $1.01B to $775.11M.
- What does asia — segment revenue mean?
- This metric represents the total revenue generated by the company's operations within the Asia geographic region. It encompasses sales from both the diagnostics and discovery and analytical solutions segments, reflecting the company's market penetration and commercial performance in these specific territories. This figure is a key indicator of regional growth trends and the company's ability to capture demand in Asian pharmaceutical, biomedical, and industrial markets.
Ask your AI about Revvity's asia — segment revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude